TransMedics Total Assets from 2010 to 2024

TMDX Stock

USD 86.71 0.40 0.46%

TransMedics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2018-06-30

Previous Quarter

758.6 M

Current Value

785.6 M

Quarterly Volatility

261.7 M

Covid

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Selling General Administrative of 125.5 M or Research Development of 22.2 M, as well as many indicators such as Price To Sales Ratio of 10.09, Dividend Yield of 0.0 or PTB Ratio of 19.64. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.

Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Total Assets Growth Pattern

Below is the plot of the Total Assets of TransMedics Group over the last few years. Total assets refers to the total amount of TransMedics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TransMedics Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. TransMedics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 706.05 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

TransMedics Total Assets Regression Statistics

	Arithmetic Mean	170,629,823
	Geometric Mean	91,868,797
	Coefficient Of Variation	136.93
	Mean Deviation	161,687,184
	Median	58,104,000
	Standard Deviation	233,638,060
	Sample Variance	54586.7T
	Range	726.4M
	R-Value	0.73
	Mean Square Error	27124.2T
	R-Squared	0.54
	Significance	0
	Slope	38,340,555
	Total Sum of Squares	764214.4T

TransMedics Total Assets History

	2024	741.3 M
	2023	706 M
	2022	277.1 M
	2021	134.9 M
	2020	152 M
	2019	105.3 M
	2018	42.2 M

Other Fundumenentals of TransMedics Group

Intangibles To Total Assets

TransMedics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.7	0.81	-0.75	0.86	0.98	-0.37	0.94	1.0	0.61	0.91	0.99	0.96	0.64	0.59	0.94	0.96	-0.91	0.99	0.14	-0.62	0.78	-0.91
Total Stockholder Equity	0.7		0.93	-0.74	0.47	0.59	-0.08	0.53	0.73	0.96	0.83	0.7	0.52	0.16	0.94	0.52	0.86	-0.49	0.77	0.62	-0.91	0.92	-0.49
Net Tangible Assets	0.81	0.93		-0.75	0.58	0.71	-0.05	0.66	0.85	0.86	0.89	0.81	0.65	0.27	0.8	0.65	0.9	-0.62	0.87	0.4	-0.92	0.95	-0.62
Retained Earnings	-0.75	-0.74	-0.75		-0.69	-0.66	0.01	-0.66	-0.78	-0.79	-0.82	-0.73	-0.6	-0.27	-0.77	-0.59	-0.82	0.58	-0.77	-0.45	0.77	-0.82	0.58
Accounts Payable	0.86	0.47	0.58	-0.69		0.9	-0.32	0.87	0.84	0.44	0.75	0.85	0.88	0.75	0.5	0.87	0.81	-0.85	0.81	0.2	-0.47	0.53	-0.85
Long Term Debt	0.98	0.59	0.71	-0.66	0.9		-0.42	0.97	0.96	0.49	0.83	0.97	1.0	0.77	0.52	0.97	0.91	-0.95	0.95	0.11	-0.5	0.66	-0.95
Short Term Investments	-0.37	-0.08	-0.05	0.01	-0.32	-0.42		-0.46	-0.34	0.02	-0.39	-0.45	-0.44	-0.14	0.03	-0.42	-0.28	0.41	-0.34	0.4	-0.21	-0.13	0.41
Total Liab	0.94	0.53	0.66	-0.66	0.87	0.97	-0.46		0.92	0.45	0.81	0.94	0.97	0.74	0.47	0.94	0.87	-0.92	0.92	0.07	-0.47	0.63	-0.92
Total Current Assets	1.0	0.73	0.85	-0.78	0.84	0.96	-0.34	0.92		0.65	0.93	0.99	0.93	0.59	0.63	0.91	0.96	-0.89	1.0	0.16	-0.67	0.83	-0.89
Common Stock	0.61	0.96	0.86	-0.79	0.44	0.49	0.02	0.45	0.65		0.77	0.6	0.42	0.08	0.97	0.46	0.79	-0.33	0.68	0.68	-0.93	0.91	-0.33
Property Plant Equipment	0.91	0.83	0.89	-0.82	0.75	0.83	-0.39	0.81	0.93	0.77		0.92	0.79	0.33	0.71	0.77	0.93	-0.75	0.94	0.21	-0.74	0.92	-0.75
Net Receivables	0.99	0.7	0.81	-0.73	0.85	0.97	-0.45	0.94	0.99	0.6	0.92		0.95	0.61	0.59	0.93	0.95	-0.91	0.99	0.11	-0.6	0.79	-0.91
Current Deferred Revenue	0.96	0.52	0.65	-0.6	0.88	1.0	-0.44	0.97	0.93	0.42	0.79	0.95		0.8	0.45	0.97	0.87	-0.95	0.92	0.06	-0.43	0.59	-0.95
Net Debt	0.64	0.16	0.27	-0.27	0.75	0.77	-0.14	0.74	0.59	0.08	0.33	0.61	0.8		0.21	0.78	0.56	-0.76	0.57	0.16	-0.15	0.12	-0.76
Long Term Debt Total	0.59	0.94	0.8	-0.77	0.5	0.52	0.03	0.47	0.63	0.97	0.71	0.59	0.45	0.21		0.47	0.8	-0.38	0.66	0.8	-0.88	0.81	-0.38
Capital Surpluse	0.94	0.52	0.65	-0.59	0.87	0.97	-0.42	0.94	0.91	0.46	0.77	0.93	0.97	0.78	0.47		0.86	-0.85	0.9	0.05	-0.47	0.62	-0.85
Net Invested Capital	0.96	0.86	0.9	-0.82	0.81	0.91	-0.28	0.87	0.96	0.79	0.93	0.95	0.87	0.56	0.8	0.86		-0.83	0.97	0.4	-0.77	0.87	-0.83
Short Long Term Debt	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83		-0.88	-0.06	0.38	-0.52	1.0
Net Working Capital	0.99	0.77	0.87	-0.77	0.81	0.95	-0.34	0.92	1.0	0.68	0.94	0.99	0.92	0.57	0.66	0.9	0.97	-0.88		0.19	-0.69	0.85	-0.88
Short Term Debt	0.14	0.62	0.4	-0.45	0.2	0.11	0.4	0.07	0.16	0.68	0.21	0.11	0.06	0.16	0.8	0.05	0.4	-0.06	0.19		-0.63	0.35	-0.06
Deferred Long Term Liab	-0.62	-0.91	-0.92	0.77	-0.47	-0.5	-0.21	-0.47	-0.67	-0.93	-0.74	-0.6	-0.43	-0.15	-0.88	-0.47	-0.77	0.38	-0.69	-0.63		-0.9	0.38
Capital Stock	0.78	0.92	0.95	-0.82	0.53	0.66	-0.13	0.63	0.83	0.91	0.92	0.79	0.59	0.12	0.81	0.62	0.87	-0.52	0.85	0.35	-0.9		-0.52
Intangible Assets	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83	1.0	-0.88	-0.06	0.38	-0.52

Click cells to compare fundamentals

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	706 M	741.3 M
Intangibles To Total Assets	0.02	0.02

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC